Omniabio vs Pluri

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/omniabio/pluri-biotech

Category	Omniabio	Pluri
Listed site	cdmo	cdmo
Summary	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.	Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production.
Services	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support	Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell-Line Development Process Development CMC Analytical Development Formulation Development Technology Transfer Cold-Chain Storage & Logistics Autologous Cell Therapy Manufacturing CMC Regulatory Submission Support Sterile Fill-Finish & Aseptic Manufacturing
Modalities	Cell Therapy Gene Therapy	Cell Therapy
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada	Headquarters, Haifa, Haifa, Israel USA Office, USA
Certifications	Data not yet provided.	FDA · Identifier: U.S. Food and Drug Administration EMA · Identifier: European Medicines Agency PMDA · Identifier: Japan's Pharmaceuticals and Medical Devices Agency
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.